Dr. Richard Peterson, Professor
Joined ERP Program: 1996

Department: Pharmacology, Faculty Profile
Address: 5109 Rennebohm Hall, 777 Highland Ave. Madison, WI 53706
Telephone: (608) 263-5453  FAX: (608) 265-3316
Email: repeterson@pharmacy.wisc.edu

Background:

Institution Degree Year Area of Study
University of WI-Madison B.S. 1967 Psychology
Marquette University Ph.D. 1972 Pharmacology

Professional Experience:

1973-1975 Instructor, Department of Pharmacology, Medical College of Wisconsin
1975-1979 Assistant Professor, School of Pharmacy, University of Wisconsin-Madison
1979-1984 Associate Professor, School of Pharmacy, University of Wisconsin-Madison
1984-Present Professor, School of Pharmacy, University of Wisconsin-Madison

Honors and Awards:

1983-1988

NIEHS, Research Career Development Award
1989-Pres Editorial Board, Toxicology and Applied Pharmacology
1993 Society of Toxicology- Frank R. Blood Award
1997-Pres Board of Scientific Counselors, National Toxicology Program
1998-Pres  Deputy Director, NIEHS Center for Developmental and Molecular Toxicology, University of Wisconsin
1998-Pres Expert Registry, NIEHS, NTP, Center for Evaluation of Risks to Human Reproduction
2000-Pres Board of Publications, Society of Toxicology

Research Statement:

The goal is to determine consequences of perinatal TCDD exposure on prostate development in the C57BL/6 mouse and elucidate mechanisms involved. Specific aims. are to identify aberrant effects of TCDD on development of ventral (VP), dorsolateral (DLP), and anterior (AP) prostate, determine using AhR knockout (AhRKO) mice if these effects require AhR, determine critical periods for producing them, elucidate androgen dependent mechanisms for causing them, determine if TCDD acts directly on urogenital sinus (UGS) or prostate to inhibit development, determine if co-exposure to a natural AhR antagonist in human food, resveratrol, ameliorates TCDD disruption of prostate development, identify during the critical period TCDD responsive genes in UGS, determine using a dose response approach TCDD responsive genes in UGS that may be involved in TCDD inhibition of prostatic budding, and determine long-term consequences of perinatal TCDD exposure on prostate size, histology, and growth in senescence.

Former ERP Graduate Students:

  • Kinarm Ko, PhD 8/03

Grant Funding:

Funding Period Project 
03/01/02 to 02/28/07 R. Peterson (PI) COMM NOAA NA16RG2257
Sea Grant FY 2002 Dioxin Developmental Toxicity in Zebrafish
06/21/04 to 05/31/07 R. Peterson (PI) NIH 5 R01 CA095751-03
Ah Receptor Regulation of Prostate Tumor Progression
02/01/05 to 01/31/07 R. Peterson (PI) NIH 5 F31 HD049323-02
Inhibition of Fetal Prostate Development by Dioxin
07/01/05 to 08/31/09 R. Peterson (PI) NSF DMR-0425880
NSEC-SEED 4 Safety Assessment Of Nanomaterials In Zebrafish
09/09/05 to 08/30/10 R. Peterson (PI) NIH 5 R37 ES001332-31
Reproductive and Developmental Toxicity of Dioxin
03/01/06 to 02/28/07 R. Peterson (PI) COMM NOAA NA06OAR4170011
FY 2006-2008 Sea Grant Program -- Early Life Stage Exposure To 2,3,7,8- Tetrachlorodebenzo-P-Dioxin
07/01/06 to 06/30/07 R. Peterson (PI) NIH via UW-Milwaukee
Marine and Freshwater Biomedical Sciences Center

 

Publications from Dr. Peterson's Lab Search PubMed